For Patients
Your Liver Is an Airport
And You’re an Air Traffic Controller Now
How Your Body Processes Every Drug, Supplement, Toxin, and Molecule You Put In It
Herxheimers. Gesundheit? Or did you mean horcrux?!
A note on the metaphor: Your liver doesn’t process everything directly, it produces enzymes and distributes them throughout your body to do the work. But to begin understanding capacity, competition, and bottlenecks, one airport tells the story. And it is your one liver producing all of those enzymes. We have additional examples below to provide patients with a framework to understand the concepts of liver enzymes and interactions.
If you’ve ever looked at a drug interaction chart and felt your brain shut down, this page is for you. CYP450 enzymes are how your liver processes almost everything that enters your body — medications, supplements, food compounds, and toxins. Understanding them is the difference between a treatment stack that works and one that poisons you. The good news: the system works exactly like an airport, and once you see it that way, it never stops making sense.
The Airport
Your liver is an airport. Every substance that enters your body — every pill, every supplement, every bite of food, every toxin your fungal infection dumps into your bloodstream — is a passenger that needs to be processed, transformed, and sent to its destination or escorted out of the building.
The airport has a fixed number of gates. It has a fixed number of planes. Each plane flies specific routes to specific destinations. And every single passenger has to get on a plane to go anywhere.
The planes are your CYP450 enzymes. The passengers are everything your body needs to process. And the whole system runs 24 hours a day, 7 days a week, with no holidays, no shutdowns, and no option to just stop because it’s busy.
The Flights
Your airport doesn’t run one kind of plane. It runs several different fleets, and each fleet flies different routes.
This is the big one. CYP3A4 is the largest fleet at your airport, handling roughly 50% of all passenger traffic. It’s a wide-body aircraft — big, flexible, can accommodate a huge variety of passengers. It flies to more destinations than any other carrier.
Passengers on this flight include: itraconazole, most calcium channel blockers, most statins, codeine, diazepam, erythromycin, fentanyl, midazolam, cyclosporine, many chemotherapy drugs, testosterone, cortisol, and estradiol. Also: some of the mycotoxins your body is trying to clear.
CYP3A4 operates out of two hubs — your liver AND your small intestine. So passengers get processed on the way in (first pass) and again once they’re in the system. This is why some drugs have low oral bioavailability — they get metabolized in the gut before they even reach the bloodstream. The plane intercepted them at the regional hub before they could transfer to the main terminal.
A smaller fleet, but critically important. Handles about 10% of prescribed drugs. This is the route that processes voriconazole, omeprazole, clopidogrel, some antidepressants, and some benzodiazepines.
Here’s where genetics matter: some people’s CYP2C19 fleet runs more flights per day than normal. These are ultra-rapid metabolizers. Their planes take off, deliver passengers, and come back to the gate faster than everyone else’s. That sounds like an advantage until you realize it means drugs clear your system faster — so a standard dose doesn’t last as long and may never reach therapeutic levels. If your doctor prescribes voriconazole and you’re a CYP2C19 ultra-rapid metabolizer, the drug may leave your system before it has time to work. It’s like booking a flight that lands, immediately reboards, and takes off again before you can get your luggage.
Other people have a slow fleet — poor metabolizers. Their planes sit at the gate longer, process passengers slower, and the terminal gets crowded. Drugs build up. Side effects intensify. A normal dose becomes an overdose because the plane just isn’t moving fast enough.
Handles about 25% of all prescribed drugs despite being a relatively small fleet. This is the route for many antidepressants, beta-blockers, opioids (tramadol, codeine, oxycodone), tamoxifen, and some antipsychotics.
CYP2D6 is the most genetically variable of all the fleets. Some people have no functional copies of this plane at all (poor metabolizers — about 6-10% of people with European ancestry). Some have extra copies (ultra-rapid metabolizers). This is why codeine kills some people and does nothing for others — codeine is a prodrug that CYP2D6 converts into morphine. No working CYP2D6, no pain relief. Too much CYP2D6, too much morphine from a standard dose.
Processes caffeine, theophylline, some antipsychotics, and melatonin. This flight is heavily affected by smoking (induces more flights — smokers clear caffeine faster) and is inhibited by grapefruit, some fluoroquinolones, and oral contraceptives.
Handles warfarin, most NSAIDs (ibuprofen, naproxen), losartan, and some oral hypoglycemics. Genetic variation here is why some people bleed on standard warfarin doses and others need much more to achieve therapeutic anticoagulation.
Smaller fleet. Processes methadone, efavirenz, bupropion, and cyclophosphamide. Highly variable between individuals.
What Happens When the Airport Gets Busy
Here’s where it matters for anyone taking more than one medication, supplement, or dealing with toxin clearance.
Overbooked Flights (Competitive Inhibition)
Two drugs need the same plane. There are only so many seats. One drug gets on, the other waits at the gate.
In real terms: you take itraconazole (CYP3A4 passenger) and a statin (also CYP3A4 passenger) at the same time. Both need the same flight. Itraconazole doesn’t just ride the plane — it also blocks the gate agent from boarding other passengers. Now the statin can’t get processed. It builds up in your blood. Your “normal” statin dose becomes a high dose because the plane that was supposed to clear it is occupied. This is how people end up with rhabdomyolysis from a statin that was fine before they started an antifungal.
Gate Agent Called in Sick (Enzyme Inhibition)
Some substances don’t just compete for seats — they shut down the gate entirely. Grapefruit juice inhibits CYP3A4 in the gut. It doesn’t compete for a seat on the plane. It fires the gate agent. Now NO CYP3A4 passengers can board at that hub until a new gate agent shows up, which can take hours to days.
This is why “don’t take with grapefruit juice” isn’t a suggestion. If you drink grapefruit juice and then take a CYP3A4-metabolized drug, the drug doesn’t get processed in your gut. Way more of it reaches your bloodstream than intended. One glass of grapefruit juice can turn a standard dose into two or three times the exposure.
Opening Extra Gates (Enzyme Induction)
Some substances do the opposite — they tell your airport to build more gates and schedule more flights. Rifampin is the most powerful inducer of CYP3A4. It can increase enzyme activity up to 10-fold. St. John’s Wort does the same thing.
Sounds great until you realize: if your CYP3A4 flights suddenly triple, every drug that uses that route gets cleared way too fast. Your itraconazole levels drop. Your birth control fails. Your immunosuppressant stops working. The plane took off before the passengers had time to do what they came to do.
Connecting Flights (Multi-Step Metabolism)
Some passengers don’t go direct. They take Flight CYP3A4 to a hub, get partially processed, and then transfer to Flight CYP2D6 for the final leg. If either flight is delayed, overbooked, or cancelled, the passenger is stuck.
Codeine is the classic example: CYP2D6 converts it to morphine (the active form). If your CYP2D6 fleet is grounded (poor metabolizer), codeine sits in the terminal doing nothing. You feel no pain relief. Your doctor thinks you’re drug-seeking. Actually, your airport just doesn’t fly that route.
The Part Nobody Tells You: Toxins Are Passengers Too
This is where it gets critical for anyone with mold illness
Your mycotoxins — ochratoxin A, gliotoxin, aflatoxin, trichothecenes — are all passengers. They need to get on a plane to be processed and removed from your body. They use the same flights as your medications.
If your CYP3A4 flights are full of itraconazole, there are fewer seats for OTA. If your Phase II conjugation gates (glutathione, glucuronidation) are backed up because too many metabolites are arriving from Phase I faster than Phase II can handle them, you get a toxic pileup in the terminal.
This is why clearance capacity matters as much as kill capacity when treating a fungal infection. Every antifungal you take occupies enzyme capacity that could be clearing toxins. Every toxin the dying fungus releases competes with your medications for the same processing pathways. Kill too fast, overwhelm your clearance, and you get sicker from the die-off than from the infection.
For mold patients specifically:
Your airport was already busy before you got sick. It processes everything you eat, clears normal metabolic waste, handles your hormones, manages whatever supplements or medications you were already taking. That’s the baseline flight schedule — the one your liver was designed to handle.
Now that you’re sick, on top of all of that, your airport is trying to do four entirely new jobs simultaneously:
Itraconazole, fluconazole, antifungal botanicals, immune support compounds
From ongoing fungal exposure or stored in your tissue
Your mitochondria are being poisoned by mycotoxins, which means they’re running inefficiently — producing less ATP while generating more reactive oxygen species and metabolic byproducts. Your body is working harder to make less energy, and the extra waste from that inefficient process needs to be cleared through the same airport that’s already overloaded with jobs 1 through 3
All four use the same planes. If you fill all the flights with job #1, jobs #2 and #3 back up. If job #3 suddenly floods the terminal (a big biofilm breakthrough kills a bunch of fungal mass at once), there aren’t enough planes for anything. That’s a Herxheimer reaction, and it’s essentially a terminal-wide gridlock where nothing moves.
Genetic Differences: Your Airport Isn’t the Same as Everyone Else’s
This is what pharmacogenomic testing tells you. It looks at your DNA and tells you which fleets run fast, which run slow, and which routes are understaffed.
Your fleet on that route runs extra flights. Drugs clear fast. Standard doses may not work. You may need higher doses or more frequent dosing.
Standard fleet schedule. Drug dosing guidelines were written for you.
Fewer flights than normal. Drugs clear slower. You may need lower doses.
Fleet is grounded or barely operational on that route. Drugs build up. Standard doses may cause toxicity. You may need much lower doses or a different drug that uses a different route entirely.
The critical point: drug dosing guidelines assume you’re a normal metabolizer. If you’re not — and roughly 40-50% of people carry at least one clinically significant CYP variant — standard doses may be wrong for you. Not slightly wrong. Dangerously wrong.
A CYP2C19 ultra-rapid metabolizer taking voriconazole at standard dose may never reach therapeutic antifungal levels. The drug clears too fast. The infection continues. The doctor thinks voriconazole “didn’t work” when actually it never had a chance. This is why pharmacogenomic testing isn’t optional for serious antifungal therapy — it tells you which drugs can actually reach effective levels in YOUR system.
A CYP2D6 poor metabolizer taking codeine gets zero pain relief. They take more, hoping it’ll work. It doesn’t. They look like they’re drug-seeking when actually their airport just doesn’t convert codeine to morphine.
Where the Flights Go: Not Every Destination Is Equal
The planes don’t just “process” drugs into nothing. They transform passengers and send them somewhere — and where they go matters.
Some flights deliver the active drug. Codeine → morphine (via CYP2D6). The drug you swallowed was inactive. The plane ride is what activated it. These are prodrugs. If the plane doesn’t fly, the drug never works.
Some flights deactivate the drug. Itraconazole gets metabolized into hydroxyitraconazole and eventually inactive compounds. The plane ride is what clears it from your system. If the plane is slow (poor metabolizer) or overbooked, the drug builds up.
Some flights create toxic intermediates. The plane takes a relatively harmless passenger and drops them off at a destination where they’re dangerous. Acetaminophen, for example — CYP2E1 converts a small fraction into NAPQI, which is hepatotoxic. Your liver handles this fine at normal doses because glutathione mops up the NAPQI. But if you deplete your glutathione (chronic illness, alcohol, NAC depletion from mycotoxin clearance) or overdose the acetaminophen, NAPQI accumulates and destroys your liver.
Some destinations are hard to reach. The blood-brain barrier is like an international terminal with extra security. Not every plane can fly there. This is why fluconazole matters for CNS fungal infections — it actually crosses the blood-brain barrier. Itraconazole mostly doesn’t. You can run all the CYP3A4 flights you want with itraconazole, but if the infection is in your brain, you need a plane that flies that route. Fluconazole is that plane.
Similarly, getting drugs to deep cardiac tissue, bone, or the eye requires compounds that distribute to those compartments. If your infection is in your maxillary bone, you need drugs that achieve therapeutic concentrations in bone. The airport can process them fine — the question is whether the drug gets off the plane at the right destination.
Running the Tower: How to Manage a Complex Stack
If you’re taking multiple medications, supplements, and clearing toxins simultaneously, you’re an air traffic controller
Before adding anything to your stack, check which CYP enzymes it uses. If your CYP3A4 flights are already full with itraconazole, adding another CYP3A4 substrate without adjusting something creates a backlog.
Get pharmacogenomic testing. Know if you’re a rapid, normal, intermediate, or poor metabolizer for each major route. This tells you which flights run on time and which are chronically delayed.
Don’t put all your CYP3A4 passengers on the same flight. If you take itraconazole and a CYP3A4-metabolized supplement at the same time, they compete. If you stagger them by a few hours, the first passenger has time to board and clear before the next one arrives at the gate.
If one route is congested, find a drug that flies a different one. This is the clinical argument for choosing itraconazole (CYP3A4) over voriconazole (CYP2C19) when your CYP2C19 is already processing other things — or vice versa, depending on your genetic status and what else is on the same route.
Phase I metabolism (CYP450) creates intermediate metabolites that need Phase II conjugation (glutathione, glucuronidation, sulfation) to become excretable. If Phase I is running faster than Phase II can handle — too many planes landing at the connecting hub — intermediates accumulate. This is why glutathione support, NAC, and glycine aren’t just “detox supplements.” They’re staffing the connecting hub so the system doesn’t bottleneck.
Your mycotoxins need seats too. If every flight is full of medications and supplements, OTA and gliotoxin wait at the gate. They build up. You feel worse. Sometimes the smartest move is to take fewer supplements so your airport has capacity to clear the toxins that are actually making you sick.
If you’re in a massive die-off — biofilm breakthrough, Herxheimer reaction, your whole body feels like it’s on fire — your terminal is flooded. The right move may be to temporarily reduce or pause antifungals (stop creating more die-off passengers) so your airport can clear the backlog. This isn’t giving up. It’s preventing a terminal-wide shutdown.
Some Compounds Skip the Airport Entirely
Not everything goes through CYP450. Some treatments use different pathways, and that’s a strategic advantage.
Allicin
Direct membrane disruption on contact. Doesn’t need to be metabolized by CYP450 to work. It kills by touching fungal membranes. This means it puts zero load on your liver’s flight schedule.
Cinnamaldehyde (topical)
Cell wall disruption at the application site. Local action. Minimal systemic CYP burden.
Cholestyramine and other binders
Bind toxins in the gut and carry them out in stool. They never enter the bloodstream, never reach the liver, never need a flight. They’re like a shuttle bus that picks up passengers at the curb and drives them straight to the exit without ever entering the terminal.
This is why a multi-mechanism antifungal strategy isn’t just about hitting the fungus from more angles. It’s about distributing the metabolic load across different processing systems so no single route gets overwhelmed. If every compound in your stack went through CYP3A4, you’d have the most congested airport in the world with empty gates on every other route. Spreading the load means more total throughput.
Quick Reference: Major Flights and Their Passengers
| Flight | Size of Fleet | Key Passengers (Drug Examples) | Notable |
|---|---|---|---|
| CYP3A4 | Largest (~50% of all drug metabolism) | Itraconazole, ketoconazole, statins, calcium channel blockers, cyclosporine, fentanyl, midazolam, cortisol, estradiol, many chemo drugs | Inhibited by grapefruit, itraconazole itself, erythromycin. Induced by rifampin, St. John’s Wort. Activity varies 100-fold between individuals. |
| CYP2C19 | Medium (~10% of drugs) | Voriconazole, omeprazole, clopidogrel, some SSRIs, some benzodiazepines | Most clinically significant genetic variation for antifungal therapy. Ultra-rapid metabolizers may fail voriconazole. |
| CYP2D6 | Medium (~25% of drugs) | Codeine, tramadol, oxycodone, tamoxifen, most SSRIs, beta-blockers, some antipsychotics | Most genetically variable. 6-10% of Europeans are poor metabolizers. Cannot be induced. |
| CYP1A2 | Smaller | Caffeine, theophylline, melatonin, some antipsychotics | Induced by smoking, cruciferous vegetables. Inhibited by fluoroquinolones, oral contraceptives. |
| CYP2C9 | Medium | Warfarin, NSAIDs (ibuprofen, naproxen), losartan, some oral diabetes drugs | Genetic variants affect warfarin dosing significantly. |
| CYP2B6 | Smaller | Methadone, efavirenz, bupropion, cyclophosphamide | Highly variable. Important in HIV and addiction medicine. |
| CYP2E1 | Smaller | Acetaminophen, ethanol, some anesthetics | Creates toxic NAPQI from acetaminophen. Induced by chronic alcohol use. |
The Takeaway
Your liver is an airport that never closes. Every drug, supplement, food compound, and toxin in your body is a passenger that needs a flight. The flights are your CYP450 enzymes. Each flight has limited seats, flies specific routes, and runs on a schedule you can influence but not fully control.
Your genetics determine how many planes are in each fleet. Your medications, supplements, and toxin load determine how many passengers are trying to board. Your job — and your doctor’s job — is to make sure the passengers that matter most get on their flights, the toxic passengers get cleared out, and nobody is stuck at the gate long enough to cause damage.
If you have mold illness, you’re running a busy airport with a lot of unexpected passengers (mycotoxins, die-off debris) competing with your scheduled passengers (medications, supplements) for the same limited flights. Understanding the flight schedule is how you keep the system running without a terminal-wide shutdown.
Get pharmacogenomic testing. Know your flights. Schedule your departures. Protect your clearance capacity. And when the terminal floods, know when to ground the fleet and let the system catch up.